Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

A Pipeline for ctDNA Detection Following Primary Tumor Profiling Using a Cancer-Related Gene Sequencing Panel.

Nishizuka SS, Sato KA, Hachiya T.

Methods Mol Biol. 2019;1908:229-241. doi: 10.1007/978-1-4939-9004-7_16.

PMID:
30649732
2.

Liver Regeneration Supported by Muse Cells.

Nishizuka SS, Suzuki Y, Katagiri H, Takikawa Y.

Adv Exp Med Biol. 2018;1103:219-241. doi: 10.1007/978-4-431-56847-6_12.

PMID:
30484232
3.

Helicobacter pylori infection is associated with favorable outcome in advanced gastric cancer patients treated with S-1 adjuvant chemotherapy.

Nishizuka SS, Tamura G, Nakatochi M, Fukushima N, Ohmori Y, Sumida C, Iwaya T, Takahashi T, Koeda K; Northern Japan Gastric Cancer Study Consortium.

J Surg Oncol. 2018 Apr;117(5):947-956. doi: 10.1002/jso.24977. Epub 2018 Jan 22.

PMID:
29355977
4.

Colony Lysate Arrays for Proteomic Profiling of Drug-Tolerant Persisters of Cancer Cell.

Kume K, Nishizuka SS.

Anal Chem. 2017 Sep 5;89(17):8626-8631. doi: 10.1021/acs.analchem.7b01215. Epub 2017 Aug 11.

PMID:
28753272
5.

Analysis of PIK3CA mutations and PI3K pathway proteins in advanced gastric cancer.

Ito C, Nishizuka SS, Ishida K, Uesugi N, Sugai T, Tamura G, Koeda K, Sasaki A.

J Surg Res. 2017 May 15;212:195-204. doi: 10.1016/j.jss.2017.01.018. Epub 2017 Jan 30.

PMID:
28550907
6.

Inhibition of PI3K suppresses propagation of drug-tolerant cancer cell subpopulations enriched by 5-fluorouracil.

Ishida K, Ito C, Ohmori Y, Kume K, Sato KA, Koizumi Y, Konta A, Iwaya T, Nukatsuka M, Kobunai T, Takechi T, Nishizuka SS.

Sci Rep. 2017 May 23;7(1):2262. doi: 10.1038/s41598-017-02548-9.

7.

Downregulation of ST6GALNAC1 is associated with esophageal squamous cell carcinoma development.

Iwaya T, Sawada G, Amano S, Kume K, Ito C, Endo F, Konosu M, Shioi Y, Akiyama Y, Takahara T, Otsuka K, Nitta H, Koeda K, Mizuno M, Nishizuka S, Sasaki A, Mimori K.

Int J Oncol. 2017 Feb;50(2):441-447. doi: 10.3892/ijo.2016.3817. Epub 2016 Dec 22.

PMID:
28035351
8.

Ductular reactions in the liver regeneration process with local inflammation after physical partial hepatectomy.

Suzuki Y, Katagiri H, Wang T, Kakisaka K, Kume K, Nishizuka SS, Takikawa Y.

Lab Invest. 2016 Nov;96(11):1211-1222. doi: 10.1038/labinvest.2016.97. Epub 2016 Sep 12.

9.
10.

α-Amanitin Restrains Cancer Relapse from Drug-Tolerant Cell Subpopulations via TAF15.

Kume K, Ikeda M, Miura S, Ito K, Sato KA, Ohmori Y, Endo F, Katagiri H, Ishida K, Ito C, Iwaya T, Nishizuka SS.

Sci Rep. 2016 May 16;6:25895. doi: 10.1038/srep25895.

11.

Intracorporeal reconstruction after laparoscopic pylorus-preserving gastrectomy for middle-third early gastric cancer: a hybrid technique using linear stapler and manual suturing.

Koeda K, Chiba T, Noda H, Nishinari Y, Segawa T, Akiyama Y, Iwaya T, Nishizuka S, Nitta H, Otsuka K, Sasaki A.

Langenbecks Arch Surg. 2016 May;401(3):397-402. doi: 10.1007/s00423-016-1378-3. Epub 2016 Feb 16.

PMID:
26883539
12.

New era of integrated cancer biomarker discovery using reverse-phase protein arrays.

Nishizuka SS, Mills GB.

Drug Metab Pharmacokinet. 2016 Feb;31(1):35-45. doi: 10.1016/j.dmpk.2015.11.009. Epub 2015 Dec 17. Review.

PMID:
26822993
13.

[Basic Studies on Locoregional Injection of a Newly Designed Chitin Sol].

Chiba T, Sugitachi A, Kume K, Segawa T, Nishinari Y, Ishida K, Noda H, Nishizuka S, Kimura Y, Koeda K, Sasaki A.

Gan To Kagaku Ryoho. 2015 Nov;42(12):1561-3. Japanese.

PMID:
26805096
14.

Individualized Mutation Detection in Circulating Tumor DNA for Monitoring Colorectal Tumor Burden Using a Cancer-Associated Gene Sequencing Panel.

Sato KA, Hachiya T, Iwaya T, Kume K, Matsuo T, Kawasaki K, Abiko Y, Akasaka R, Matsumoto T, Otsuka K, Nishizuka SS.

PLoS One. 2016 Jan 4;11(1):e0146275. doi: 10.1371/journal.pone.0146275. eCollection 2016.

15.

A Distinct Subpopulation of Bone Marrow Mesenchymal Stem Cells, Muse Cells, Directly Commit to the Replacement of Liver Components.

Katagiri H, Kushida Y, Nojima M, Kuroda Y, Wakao S, Ishida K, Endo F, Kume K, Takahara T, Nitta H, Tsuda H, Dezawa M, Nishizuka SS.

Am J Transplant. 2016 Feb;16(2):468-83. doi: 10.1111/ajt.13537. Epub 2015 Dec 11.

16.

Systematic Protein Level Regulation via Degradation Machinery Induced by Genotoxic Drugs.

Kume K, Ishida K, Ikeda M, Takemoto K, Shimura T, Young L, Nishizuka SS.

J Proteome Res. 2016 Jan 4;15(1):205-15. doi: 10.1021/acs.jproteome.5b00759. Epub 2015 Dec 14.

PMID:
26625007
17.

Long-term outcomes of laparoscopic versus open liver resection for liver metastases from colorectal cancer: A comparative analysis of 168 consecutive cases at a single center.

Hasegawa Y, Nitta H, Sasaki A, Takahara T, Itabashi H, Katagiri H, Otsuka K, Nishizuka S, Wakabayashi G.

Surgery. 2015 Jun;157(6):1065-72. doi: 10.1016/j.surg.2015.01.017. Epub 2015 Mar 16.

PMID:
25791030
18.

Hyperglycemia 3 days after esophageal cancer surgery is associated with an increased risk of postoperative infection.

Ito N, Iwaya T, Ikeda K, Kimura Y, Akiyama Y, Konosu M, Ishida K, Fujiwara H, Otsuka K, Nitta H, Kashiwaba M, Koeda K, Nishizuka S, Mizuno M, Sasaki A, Wakabayashi G.

J Gastrointest Surg. 2014 Sep;18(9):1547-56. doi: 10.1007/s11605-014-2587-0. Epub 2014 Jul 4.

PMID:
24992996
19.

Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (Reverse Phase Protein Array) society.

Akbani R, Becker KF, Carragher N, Goldstein T, de Koning L, Korf U, Liotta L, Mills GB, Nishizuka SS, Pawlak M, Petricoin EF 3rd, Pollard HB, Serrels B, Zhu J.

Mol Cell Proteomics. 2014 Jul;13(7):1625-43. doi: 10.1074/mcp.O113.034918. Epub 2014 Apr 28.

20.

Efficacy of occlusion of hepatic artery and risk of carbon dioxide gas embolism during laparoscopic hepatectomy in a pig model.

Makabe K, Nitta H, Takahara T, Hasegawa Y, Kanno S, Nishizuka S, Sasaki A, Wakabayashi G.

J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):592-8. doi: 10.1002/jhbp.103. Epub 2014 Apr 21.

PMID:
24753492
21.

A compensatory role of NF-κB to p53 in response to 5-FU-based chemotherapy for gastric cancer cell lines.

Endo F, Nishizuka SS, Kume K, Ishida K, Katagiri H, Ishida K, Sato K, Iwaya T, Koeda K, Wakabayashi G.

PLoS One. 2014 Feb 27;9(2):e90155. doi: 10.1371/journal.pone.0090155. eCollection 2014.

22.

[Photodynamic diagnosis and preoperative chemotherapy for biliary tract cancer].

Ito N, Sugitachi A, Takahashi M, Makabe K, Kanno S, Hasegawa Y, Takahara T, Fujita T, Nishizuka S, Nitta H, Wakabayashi G.

Gan To Kagaku Ryoho. 2013 Nov;40(12):1641-3. Japanese.

PMID:
24393874
23.

Contrasting expression patterns of histone mRNA and microRNA 760 in patients with gastric cancer.

Iwaya T, Fukagawa T, Suzuki Y, Takahashi Y, Sawada G, Ishibashi M, Kurashige J, Sudo T, Tanaka F, Shibata K, Endo F, Katagiri H, Ishida K, Kume K, Nishizuka S, Iinuma H, Wakabayashi G, Mori M, Sasako M, Mimori K.

Clin Cancer Res. 2013 Dec 1;19(23):6438-49. doi: 10.1158/1078-0432.CCR-12-3186. Epub 2013 Oct 4.

24.

Laparoendoscopic single site adrenalectomy: initial results of cosmetic satisfaction and the potential for postoperative pain reduction.

Sasaki A, Nitta H, Otsuka K, Nishizuka S, Baba S, Umemura A, Koeda K, Mizuno M, Wakabayashi G.

BMC Urol. 2013 Apr 12;13:21. doi: 10.1186/1471-2490-13-21.

25.

Laparoscopic left lateral sectionectomy as a training procedure for surgeons learning laparoscopic hepatectomy.

Hasegawa Y, Nitta H, Sasaki A, Takahara T, Ito N, Fujita T, Kanno S, Nishizuka S, Wakabayashi G.

J Hepatobiliary Pancreat Sci. 2013 Jun;20(5):525-30. doi: 10.1007/s00534-012-0591-x.

PMID:
23430054
26.

Evaluation of chemosensitivity prediction using quantitative dose-response curve classification for highly advanced/relapsed gastric cancer.

Matsuo T, Nishizuka SS, Ishida K, Endo F, Katagiri H, Kume K, Ikeda M, Koeda K, Wakabayashi G.

World J Surg Oncol. 2013 Jan 22;11:11. doi: 10.1186/1477-7819-11-11.

27.

[Usefulness of esophageal stenting for esophagorespiratory fistula with esophageal cancer].

Konosu M, Kimura Y, Iwaya T, Akiyama Y, Fujiwara H, Endo F, Sugitachi A, Nishizuka S, Nitta H, Otsuka K, Kashiwaba M, Koeda K, Sasaki A, Mizuno M, Wakabayashi G.

Gan To Kagaku Ryoho. 2012 Nov;39(12):1849-51. Japanese.

PMID:
23267907
28.

Molecular marker identification for relapse prediction in 5-FU-based adjuvant chemotherapy in gastric and colorectal cancers.

Ishida K, Nishizuka SS, Chiba T, Ikeda M, Kume K, Endo F, Katagiri H, Matsuo T, Noda H, Iwaya T, Yamada N, Fujiwara H, Takahashi M, Itabashi T, Uesugi N, Maesawa C, Tamura G, Sugai T, Otsuka K, Koeda K, Wakabayashi G.

PLoS One. 2012;7(8):e43236. doi: 10.1371/journal.pone.0043236. Epub 2012 Aug 14.

29.

Totally laparoscopic stapled distal pancreatectomy.

Katagiri H, Sasaki A, Nitta H, Takahara T, Nishizuka S, Wakabayashi G.

Surg Today. 2012 Oct;42(10):940-4. doi: 10.1007/s00595-012-0218-5. Epub 2012 Jul 13.

PMID:
22790708
30.

A phase I study for adjuvant chemotherapy of gemcitabine plus S-1 in curatively resected patients with biliary tract cancer: adjusting the dose of adjuvant chemotherapy according to the surgical procedures.

Takahara T, Nitta H, Hasegawa Y, Itou N, Takahashi M, Nishizuka S, Wakabayashi G.

Cancer Chemother Pharmacol. 2012 May;69(5):1127-33. doi: 10.1007/s00280-011-1805-7. Epub 2011 Dec 30.

PMID:
22207029
31.

[A novel gemcitabine delivery system].

Sugitachi A, Ikeda M, Matsuo T, Nishizuka S, Nitta H, Takahashi M, Takahara T, Ito N, Hasegawa Y, Wakabayashi G.

Gan To Kagaku Ryoho. 2011 Nov;38(12):2445-7. Japanese.

PMID:
22202408
32.

[A novel Cisplatin delivery system for malignant ascites-bearing mice-a basic experimentation].

Itabashi T, Sugitachi A, Kimura Y, Ikeda M, Kumagai M, Matsuo T, Fujii H, Nishizuka S, Otsuka K, Koeda K, Sasaki A, Wakabayashi G.

Gan To Kagaku Ryoho. 2011 Nov;38(12):2081-3. Japanese.

PMID:
22202290
33.

Reverse-phase protein lysate microarray (RPA) for the experimental validation of quantitative protein network models.

Nishizuka SS.

Methods Mol Biol. 2011;785:65-77. doi: 10.1007/978-1-61779-286-1_6.

PMID:
21901594
34.

Analysis of the anti-tumor effect of cetuximab using protein kinetics and mouse xenograft models.

Matsuo T, Nishizuka SS, Ishida K, Iwaya T, Ikeda M, Wakabayashi G.

BMC Res Notes. 2011 May 10;4:140. doi: 10.1186/1756-0500-4-140.

35.

Our initial experience with robotic hepato-biliary-pancreatic surgery.

Wakabayashi G, Sasaki A, Nishizuka S, Furukawa T, Kitajima M.

J Hepatobiliary Pancreat Sci. 2011 Jul;18(4):481-7. doi: 10.1007/s00534-011-0388-3. Review.

PMID:
21487755
36.

Minimally invasive surgery for gastric cancer: the future standard of care.

Koeda K, Nishizuka S, Wakabayashi G.

World J Surg. 2011 Jul;35(7):1469-77. doi: 10.1007/s00268-011-1051-5. Review.

PMID:
21476116
37.

Laparoscopy-assisted appendectomy through an umbilical port in children.

Fukuzawa T, Mizuno M, Nakajima J, Nishizuka S, Kimura Y, Otsuka K, Nitta H, Kashiwaba M, Koeda K, Sasaki A, Wakabayashi G.

Asian J Endosc Surg. 2011 Feb;4(1):11-5. doi: 10.1111/j.1758-5910.2010.00069.x.

PMID:
22776168
38.

[Anticancer efficacy with cisplatin delivery systems].

Sugitachi A, Kimura Y, Itabashi T, Ikeda M, Ishida K, Noda H, Matsuo T, Nishizuka S, Otsuka K, Koeda K, Sato A, Takahashi T, Wakabayashi G.

Gan To Kagaku Ryoho. 2010 Nov;37(12):2274-6. Japanese.

PMID:
21224545
39.

Risk factors for early postoperative small bowel obstruction after colectomy for colorectal cancer.

Nakajima J, Sasaki A, Otsuka K, Obuchi T, Nishizuka S, Wakabayashi G.

World J Surg. 2010 May;34(5):1086-90. doi: 10.1007/s00268-010-0462-z.

PMID:
20151126
40.

Laparoscopy-assisted major liver resections employing a hanging technique: the original procedure.

Nitta H, Sasaki A, Fujita T, Itabashi H, Hoshikawa K, Takahara T, Takahashi M, Nishizuka S, Wakabayashi G.

Ann Surg. 2010 Mar;251(3):450-3. doi: 10.1097/SLA.0b013e3181cf87da.

PMID:
20083994
41.

Multifactorial regulation of E-cadherin expression: an integrative study.

Reinhold WC, Reimers MA, Lorenzi P, Ho J, Shankavaram UT, Ziegler MS, Bussey KJ, Nishizuka S, Ikediobi O, Pommier YG, Weinstein JN.

Mol Cancer Ther. 2010 Jan;9(1):1-16. doi: 10.1158/1535-7163.MCT-09-0321. Epub 2010 Jan 6.

42.

[A novel formulation of cisplatin (CDDP)].

Sugitachi A, Kimura Y, Itabashi T, Noda H, Ishida K, Nishizuka S, Otsuka K, Kashiwaba M, Nitta H, Koeda K, Mizuno M, Sasaki A, Ikeda K, Takamori Y, Wakabayashi G.

Gan To Kagaku Ryoho. 2009 Nov;36(12):2294-6. Japanese.

PMID:
20037400
43.

Quantitative assessment of gene methylation in neoplastic and non-neoplastic gastric epithelia using methylation-specific DNA microarray.

Tamura G, So K, Miyoshi H, Honda T, Nishizuka S, Motoyama T.

Pathol Int. 2009 Dec;59(12):895-9. doi: 10.1111/j.1440-1827.2009.02458.x.

PMID:
20021617
44.

Tailored laparoscopic resection for suspected gastric gastrointestinal stromal tumors.

Sasaki A, Koeda K, Obuchi T, Nakajima J, Nishizuka S, Terashima M, Wakabayashi G.

Surgery. 2010 Apr;147(4):516-20. doi: 10.1016/j.surg.2009.10.035. Epub 2009 Dec 11.

PMID:
20004449
45.

Ten-year experience of totally laparoscopic liver resection in a single institution.

Sasaki A, Nitta H, Otsuka K, Takahara T, Nishizuka S, Wakabayashi G.

Br J Surg. 2009 Mar;96(3):274-9. doi: 10.1002/bjs.6472.

PMID:
19224518
46.

[High density 'reverse-phase' protein lysate microarray].

Nishizuka S, Ishida K, Noda H, Takahashi M, Wakabayashi G.

Seikagaku. 2008 Nov;80(11):1047-54. Review. Japanese. No abstract available.

PMID:
19086413
47.

Reverse-phase protein lysate microarrays for cell signaling analysis.

Spurrier B, Ramalingam S, Nishizuka S.

Nat Protoc. 2008;3(11):1796-808. doi: 10.1038/nprot.2008.179.

PMID:
18974738
48.

Protein and lysate array technologies in cancer research.

Spurrier B, Honkanen P, Holway A, Kumamoto K, Terashima M, Takenoshita S, Wakabayashi G, Austin J, Nishizuka S.

Biotechnol Adv. 2008 Jul-Aug;26(4):361-9. doi: 10.1016/j.biotechadv.2008.04.002. Epub 2008 Apr 20. Review.

PMID:
18514460
49.

[Application of quantitative proteomic analysis for cancer therapy using "reverse-phase" protein lysate microarrays].

Nishizuka S, Spurrier B, Honkanen P, Austin J, Wakabayashi G.

Gan To Kagaku Ryoho. 2008 Feb;35(2):200-5. Japanese.

PMID:
18281757
50.

Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers.

Stevens EV, Nishizuka S, Antony S, Reimers M, Varma S, Young L, Munson PJ, Weinstein JN, Kohn EC, Pommier Y.

Mol Cancer Ther. 2008 Jan;7(1):10-8. doi: 10.1158/1535-7163.MCT-07-0192. Epub 2008 Jan 9.

Supplemental Content

Loading ...
Support Center